Damen CA - Search Results

1

Effect of culture conditions on endothelial cell growth and responsiveness.

Relou IA, Damen CA, van der Schaft DW, Groenewegen G, Griffioen AW. Relou IA, et al. Among authors: damen ca. Tissue Cell. 1998 Oct;30(5):525-30. doi: 10.1016/s0040-8166(98)80032-3. Tissue Cell. 1998. PMID: 9839475

2

Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors.

Griffioen AW, Damen CA, Martinotti S, Blijham GH, Groenewegen G. Griffioen AW, et al. Among authors: damen ca. Cancer Res. 1996 Mar 1;56(5):1111-17. Cancer Res. 1996. PMID: 8640769

3

Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium.

Griffioen AW, Damen CA, Blijham GH, Groenewegen G. Griffioen AW, et al. Among authors: damen ca. Blood. 1996 Jul 15;88(2):667-73. Blood. 1996. PMID: 8695814 Free article.

4

CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells.

Griffioen AW, Coenen MJ, Damen CA, Hellwig SM, van Weering DH, Vooys W, Blijham GH, Groenewegen G. Griffioen AW, et al. Among authors: damen ca. Blood. 1997 Aug 1;90(3):1150-9. Blood. 1997. PMID: 9242547 Free article.

5

Endothelial CD34 is suppressed in human malignancies: role of angiogenic factors.

Hellwig SM, Damen CA, van Adrichem NP, Blijham GH, Groenewegen G, Griffioen AW. Hellwig SM, et al. Among authors: damen ca. Cancer Lett. 1997 Dec 9;120(2):203-11. doi: 10.1016/s0304-3835(97)00310-8. Cancer Lett. 1997. PMID: 9461038

6

Angiogenesis inhibitors overcome tumor induced endothelial cell anergy.

Griffioen AW, Damen CA, Mayo KH, Barendsz-Janson AF, Martinotti S, Blijham GH, Groenewegen G. Griffioen AW, et al. Among authors: damen ca. Int J Cancer. 1999 Jan 18;80(2):315-9. doi: 10.1002/(sici)1097-0215(19990118)80:2<315::aid-ijc23>3.0.co;2-l. Int J Cancer. 1999. PMID: 9935216

7

The angiogenic factor bFGF impairs leukocyte adhesion and rolling under flow conditions.

Griffioen AW, Relou IA, Gallardo Torres HI, Damen CA, Martinotti S, De Graaf JC, Zwaginga JJ, Groenewegen G. Griffioen AW, et al. Among authors: damen ca. Angiogenesis. 1998;2(3):235-43. doi: 10.1023/A:1009237324501. Angiogenesis. 1998. PMID: 14517463

8

Endoglin/CD 105 may not be an optimal tumor endothelial treatment target.

Griffioen AW, Damen CA, Blijham GH, Groenewegen G. Griffioen AW, et al. Among authors: damen ca. Breast Cancer Res Treat. 1996;39(2):239-42. doi: 10.1007/BF01806191. Breast Cancer Res Treat. 1996. PMID: 8872333 No abstract available.

9

Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3.

Scheven BA, van der Veen MJ, Damen CA, Lafeber FP, Van Rijn HJ, Bijlsma JW, Duursma SA. Scheven BA, et al. Among authors: damen ca. J Bone Miner Res. 1995 Jun;10(6):874-80. doi: 10.1002/jbmr.5650100608. J Bone Miner Res. 1995. PMID: 7572311

10

Comparison of the action of 17 beta-estradiol and progestins with insulin-like growth factors-I/-II and transforming growth factor-beta 1 on the growth of normal adult human bone-forming cells.

Verhaar HJ, Damen CA, Duursma SA, Scheven BA. Verhaar HJ, et al. Among authors: damen ca. Maturitas. 1995 Apr;21(3):237-43. doi: 10.1016/0378-5122(94)00883-9. Maturitas. 1995. PMID: 7616873

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters